Finerenone (BAY94-8862)
17530
Phase 3 small_molecule completed
Quick answer
Finerenone (BAY94-8862) for Diabetic Kidney Disease is a Phase 3 program (small_molecule) at Bayer HealthCare AG with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Bayer HealthCare AG
- Indication
- Diabetic Kidney Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed